Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Phase II data reported for cabozantinib in type I neurofibromatosis with PNs

Jan. 19, 2021

Dosing begins in phase IIa study of STP-705 for cutaneous basal cell carcinoma

Jan. 18, 2021

Nanjing Sanhome Pharmaceutical patents PRMT5 inhibitors

Jan. 18, 2021

CCS-1477, novel p300/CBP inhibitor with promising activity in prostate cancer

Jan. 18, 2021

With partner in crime, MYC repairs DNA breaks

Jan. 18, 2021

Discovery and characterization of specific inhibitors of human mitochondrial transcription

Jan. 18, 2021

FDA approves Xalkori for ALK-positive ALCL in children and young adults

Jan. 15, 2021

Mis-spliced RNAs in tumor cells trigger antiviral response

Jan. 15, 2021

New classification scheme for glioblastomas

Jan. 15, 2021

CJ-2360 achieves complete tumor regression in ALK-positive xenografts

Jan. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...